Task: Answer the MCQ question.
Question: Which compound exhibits a 39.313% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) Cn1c(=O)c2c(nc(CN3CCc4ccccc4C3)n2Cc2ccc(Cl)cc2)n(C)c1=O
b) CCOC(=O)/C(=N\Nc1cc(Cl)ccc1Cl)N1CCN(CC)CC1
c) O=S([O-])(=Nc1nc2ccccc2nc1-[n+]1ccc(CCCc2ccccc2)cc1)c1cccs1
d) NC(=O)c1ccc(NC(=O)C2COc3ccccc3O2)cc1
e) CCC(=O)Nc1ccc2nc3c(=O)[nH]c(=S)[nH]c3nc2c1
Answer: e. CCC(=O)Nc1ccc2nc3c(=O)[nH]c(=S)[nH]c3nc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1ccc2nc3c(=O)[nH]c(=S)[nH]c3nc2c1
CCC(=O)Nc1ccc2nc3c(=O)[nH]c(=S)[nH]c3nc2c1
N-(4-oxo-2-sulfanylidene-1H-benzo[g]pteridin-8-yl)propanamide